Quantum Biosystems develops quantum-based biosensing technologies for life science research and molecular detection. The company creates platforms that leverage quantum mechanical principles to detect and analyze biological molecules at unprecedented sensitivity levels. Founded in 2013, headquartered in Osaka, Japan, The company has raised $35.0M at the Series C stage, backed by investors including SBI Investment, INCJ, Mitsubishi UFJ Capital, UTEC, Mizuho Financial Group. The company operates in the Life Sciences > Genomics, Life Sciences > Life Sciences Platforms and Tools, High Tech > Nanotechnology sector. with business models spanning Nanotechnology > Nanotools > Genomics > DNA Sequencing, Quantum Computing > Applications > Life Sciences. serving markets in Japan. Developing DNA sequencers based on quantum mechanics..
Quantum Biosystems
Series CQuantum Biosystems develops quantum-based biosensing technologies for life science research and molecular detection. The company creates platforms that leverage quantum mechanical principles to detect and analyze biological molecules at unprecedented sensitivity levels. Founded in 2013, headquartered in Osaka, Japan, The company has raised $35.0M at the Series C stage, backed by investors including SBI Investment,…
About
Business model
Nanotechnology > Nanotools > Genomics > DNA Sequencing,
Quantum Computing > Applications > Life Sciences,
Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing,
Life Sciences Platforms and Tools > Instruments > Genomics > Nucleic Acid Sequencing
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Backed by funds in our directory
SBI Investment Korea
Investor profile on CrackTheDeckINCJ
Investor profile on CrackTheDeckUTEC
Investor profile on CrackTheDeck🗂️ See who's investing in Life Sciences — full fund directory with check size and geography.